ºÚÁÏÍø

Skip to main content
Our ObGyn Resident Speakers with Dr. Neal-Perry and Dr. Swisher
Our ObGyn Resident Speakers with Dr. Neal-Perry and Dr. Swisher

Faculty and residents from the University of North Carolina at Chapel Hill School of Medicine – Department of Obstetrics and Gynecology, attended and presented at the 40th Annual William Droegemueller Departmental Research Day on May 14th, 2025. 

The School of Medicine had seven resident speakers present inside Kenan Center at Kenan-Flagler Business School:

  • Lauren Ahlschlager, MD
    • ABSTRACT- Exploring Urogyn Deserts: A Geostatistical Analysis of Access to Urogynecology Care in the U.S.
  • Janina Baldino, MD
    • ABSTRACT- DRAGS – Patient Perspectives on Fertility Counseling in Gender-Affirming
  • Tressa Ellett, MD
    • ABSTRACT- Short interpregnancy interval birth rates and Title X clinic access: A North Carolina county analysis
  • Ayanna Garland, MD
    • ABSTRACT- Factors Associated with Perceived Medical Discrimination amongst Pregnant Black Patients
  • Leslie Peralta, MD
    • ABSTRACT- Pre-Treatment Albumin as a Predictor of Chemotherapy Disruption among Women with Ovarian Cancer
  • Natalie Satterfield, MD
    • ABSTRACT- Umbilical artery doppler and its association with stillbirth: Findings from a Zambian cohort
  • Beatriz Vega, MD
    • ABSTRACT- Risk factors for Preterm Birth following Open Myelomeningocele Repair
  • Kevin Tam, MD was away and will be presenting his work next year at the 2026 Ob/Gyn Resident Research Day.

The Keynote Speaker for the 2025 Resident Research Day was Dr. Elizabeth Swisher, a clinician scientist, Professor of Gynecologic Oncology, and Adjunct Professor in Medical Genetics at the University of Washington. She is Deputy Director of the Fred Hutchinson/University of Washington/Seattle Children’s Cancer Consortium and co-leads the Breast and Ovary Cancer Program. The primary focus of Dr. Swisher’s lab is the molecular genetics of ovarian cancer with a view towards improving both prevention and therapeutics. She has been closely involved in the therapeutic development of PARP inhibitors and has a clinical focus on genetics and clinical trials. She has also focused on improving our understanding of genetic risk of ovarian cancers with a goal to increase access to genetic testing and reducing the number of women who die of hereditary ovarian cancer.

Continuing the theme of academic excellence, a poster session was held, allowing other doctors to showcase the research they have been working on.

  • John Chawezi Chapola, PhD Candidate – Crafting Effective HPV Screening Result Short Message Service text: Perspectives and Recommendations from Women in Malawi
  • Katie Mollan, PhD Candidate – Effectiveness of Levonorgestrel Implant and Depot Medroxyprogesterone Acetate Injectable for Women Living with HIV on Dolutegravir-based Antiretroviral Therapy
  • Cordelia Muir, MD Candidate – Crisis Pregnancy Centers in North Carolina: Geographic Distribution, Social Media Presence, and Access to Care
  • Hannaneh Mirmozaffari, MD Candidate – Defining Phenotype of Severe Preeclampsia